Explainer: microRNA, the puppet master of the ... - CLL Support

CLL Support

23,138 members39,744 posts

Explainer: microRNA, the puppet master of the genome and its promise as a multi cancer drug

AussieNeil profile image
AussieNeilPartnerAdministrator
0 Replies

"Up until about two decades ago, one type of RNA, called microRNA, or just miRNA – by virtue of them being very short, only 18-25 letters long – were thought to be the junk mail of the genome, with no biological function. But today we know that these miRNA are actually not junk but play a very important role in regulating the activity of other parts of your DNA.

:

:

it turns out that the 98% of our genome that was regarded as “junk” might have a function after all.

The second miRNA was not discovered for another seven years. But since then, more than 1,800 human miRNAs have been found. We now understand that miRNA control numerous genes and processes vital for cellular life such as metabolism, development and the immune system.

:

:

One promising application of miRNAs is their potential as biomarkers and therapeutics in cancer.

A 2002 study found two miRNAs were deleted in 68% of chronic lymphocytic leukemias."

Pamela Ajuyah, PhD student in molecular biology and Nham Tran, Lab Head at University of Technology, Sydney explain more of how microRNA (miRNA) functions and how our growing understanding of how they function "suggests that the future of cancer therapy may lay with miRNA-based drugs that can target multiple genes, and therefore affect multiple pathways involved in cancer. This moves us on from the “one drug, one target” approach."

theconversation.com/explain...

Neil

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

FISH testing and chromosomes for dummies

I am betting most of us had a cll tabula rasa at diagnosis, that is, our knowledge of cll was a...

NICE drug approval and The Cancer Drug Fund

How novel treatment technologies are presented to organisations like NICE for approval is very...

CLL - a Cancer of the Immune System

By understanding how CLL impacts our bodies and taking the necessary precautions, we can greatly...

The promise of Mix and Match COVID-19 vaccinations

A couple of papers published in Nature provide some encouraging indications of why a 'mix and...

An exercise pill would be prescribed to every cancer patient worldwide and viewed as a major breakthrough in cancer treatment

Today, Australia’s peak body representing health professionals who treat people with cancer, has...